Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

BACKGROUND: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC). MATERIALS AN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fountzilas, George, Dafni, Urania, Bobos, Mattheos, Batistatou, Anna, Kotoula, Vassiliki, Trihia, Helen, Malamou-Mitsi, Vassiliki, Miliaras, Spyros, Chrisafi, Sofia, Papadopoulos, Savvas, Sotiropoulou, Maria, Filippidis, Theodoros, Gogas, Helen, Koletsa, Triantafyllia, Bafaloukos, Dimitrios, Televantou, Despina, Kalogeras, Konstantine T., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Koutras, Angelos, Dimopoulos, Meletios A.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3367950/
https://ncbi.nlm.nih.gov/pubmed/22679488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037946
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars